A hepatitis B vaccine trial in newborns planned in Guinea-Bissau will not proceed because the government did not authorize it, its principal investigator, Danish researcher Frederik Schaltz-Buchholzer, said. “The military government has announced that they do not authorize the trial,” and it “will therefore not happen,” he told The BMJ (opens in new tab). On LinkedIn he wrote that it was “now clear” the study “will not move forward in Guinea-Bissau,” adding, “we were not given the necessary governmental approval,” The Guardian (opens in new tab) reported.

Guinea-Bissau’s judicial police searched the Bandim Health Project’s offices in Bissau on Monday and seized a batch of hepatitis B vaccines, The Guardian (opens in new tab) and The BMJ (opens in new tab) reported. In a Facebook post, translated from Portuguese by Ars Technica (opens in new tab), the police said the seizure “constitutes an investigative procedure and does not allow, in itself, to conclude the existence of irregularities in the quality, safety, or effectiveness of the vaccines.”

The study would have withheld the birth dose from half of the participants, CIDRAP (opens in new tab) reported. It was to be funded with $1.6 million from the U.S. Centers for Disease Control and Prevention and another $1.6 million from private partners, The Guardian (opens in new tab) reported. The World Health Organization had called the trial unethical, saying hepatitis B vaccination at birth is an “essential public health intervention,” according to CIDRAP (opens in new tab). Health Minister Quinhin Nantote had told The Guardian (opens in new tab), speaking in Portuguese, “This is not even remotely true,” in response to reports the trial would proceed.

Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia who criticized the study as unethical, told The Guardian (opens in new tab): “The solution is clear here: take the money and vaccinate as many kids as you can.” Schaltz-Buchholzer said he believes the study was canceled because it challenges “prevailing medical assumptions,” The Guardian (opens in new tab) reported. Ars Technica (opens in new tab) reported that Health Secretary Robert F. Kennedy Jr. has praised the project’s lead researchers, Peter Aaby and Christine Stabell Benn, who it said are under investigation by Danish authorities for alleged scientific misconduct.